Abstract
Purpose
In recent years, the number of elderly cochlear implant (CI) candidates is continuously rising. In addition to the audiological improvement, other positive effects of CI treatment can also be observed in clinical routine. The “quality of life” as a parameter of success directly experienced by the patient is increasingly becoming the focus of clinical research. Although there are already clear indications of a rapid and significant improvement in quality of life, there is still a lack of systematic, prospectively collected longitudinal long-term data in patients over the age of 65.
Methods
This prospective longitudinal observational study included 31 patients between the age of 71 and 92 years who had first been treated unilaterally with a CI 6 years ago. In addition to free-field monosyllable recognition, quality of life was assessed using the World Health Organization Quality-of-Life Scale-old (WHOQL-OLD). The results were compared with the data from our previous study, in which we focused on the short- and medium-term effects on quality of life. In both studies, the same patient population was examined. In addition, these study data were compared with an age-matched average population.
Results
In speech recognition, there was no significant change from the control 6 months postoperatively compared with the results 6 years postoperatively. No significant changes occurred in the total quality of life score or any of the other six facets of quality of life when comparing the results 6 months postoperatively with the results 6 years postoperatively. In “Social participation”, the CI patients even exceed the values of the age-matched average population 6 years after treatment.
Conclusion
Improvement in the quality of life and especially in social participation appears stable over many years in elderly patients after hearing rehabilitation with a CI.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The cochlear implant (CI) has been successfully used for hearing rehabilitation of deaf and severely hearing-impaired patients for over three decades. While initially, only completely deaf patients were treated with a CI, the indication for a CI has been successfully extended [1,2,3]. Severe hearing loss is one of the most common chronic conditions in the elderly population [4,5,6]. As a result of demographic change in Europe, the proportion of elderly and very aged CI candidates has been steadily increasing in recent years. With a comparable—but more variable—improvement in speech comprehension compared to younger patients, CI treatment in Germany is offered without an age limit for suitable CI candidates [7,8,9,10]. Moreover, an increasing number of studies demonstrate not only the stability of monosyllable recognition but even in many cases, an improvement after more than 1 year postoperatively [11,12,13]. Especially in elderly patients, further effects beyond the audiological measurable improvements can usually be observed in clinical routine. Due to the specific psychosocial situation of higher age with common loss of social interaction and an increasing physical impairment, this age group benefits from hearing rehabilitation in particular. The influence of hearing rehabilitation on social participation and, therefore, on the quality of life, previously significantly limited by the hearing disorder, is ultimately the CI-treatment success directly experienced by the patient. Consequently, the assessment of the quality of life has developed into an important instrument for evaluating the success of treatment and has now also been implemented in the German Whitebook on Cochlear Implant Care, the German Cochlear Implant Guideline and in the German Cochlear Implant Registry [15,16,17,18].
In the literature, there are numerous indications for a rapid and significant improvement in the quality of life in the elderly related to CI treatment. Innumerable studies use questionnaires to assess health-related quality of life, such as the widely used Nijmegen Cochlear Implant Questionnaire. Apart from a lack of validation for elderly patients, a valid comparison with an age-matched healthy general population is impossible. Most studies focus on the short- and medium-term effects of hearing rehabilitation on the quality of life [19,20,21,22,23,24,25]. Consequently, the aim of this prospective longitudinal study was to observe the same patient population several years after CI implantation and to compare the study cohort with an age-matched healthy general population.
Patients and methods
Study design
This prospective long-term study is a follow-up to our previous study (Issing et al. [19]). For the initial study, candidates were recruited at our institution from the third quarter of 2015 until the third quarter of 2017. For the presented study, patients already recruited into the initial study of 2020 were followed up at annual checkups about 6 years postoperatively after initial unilateral CI treatment. Data for this study were collected from the second quarter of 2022 through the first quarter of 2023. The data from this study were compared with the results of our initial study (Issing et al. [19]). The study was conducted in accordance with the Declaration of Helsinki 1964, and with approval of the local ethical review committee (105/15). All patients gave their written informed consent for inclusion before they participated in this study.
Patients
Thirty-one patients (12 men and 19 women) of the 34 patients (13 men and 21 women) initially 2020 recruited could be included in this study. One patient was excluded as the CI had to be explanted due to implant infection; two patients could not participate in the survey due to health problems not related to the CI.
Freiburg monosyllabic speech test (FMS)
Audiological data collected during the 6 year CI aftercare as part of routine clinical practice were analyzed. The Freiburg monosyllabic speech test (FMS) at 65 dB SPL was used to evaluate the monosyllable recognition in the free field. For the continuous monitoring of monosyllable recognition over the years, the ear (first) treated with a CI was continuously evaluated with the FMS, and the other ear was masked by broadband noise or mechanical blocking.
Quality of life assessment
Our study aimed to assess the quality of life over the years in patients who had been treated with a CI for the first time. To be able to compare the results with our previous study, we used the German version of the World Health Organization Quality-of-Life Scale—old (WHOQL-OLD) according to Conrad et al. [26].
This tool is well validated for older adults from the age over 60 years and reflects the multidimensionality of the quality of life over different dimensions with so-called facets. The questionnaire consists of 24 multiple-choice questions, each with five response categories. The total quality of life score is formed from the individual facets. Six facets are distinguished in detail:
“Sensory abilities”
Central to our study, this facet generally captures patients’ assessment of their sensory functions (such as hearing, seeing, or tasting) [26].
“Autonomy”
The ability to live independently and self-determined is assessed by this facet [26].
“Past, present and future activities”
This facet captures achievements already made in life, current activities, and those planned for the future [26].
“Social participation”
Social participation in daily life as an essential factor for the quality of life is assessed here [26].
“Death and dying”
This facet includes attitudes and fears regarding one's death or the death of loved ones [26].
“Intimacy”
Interpersonal closeness and the importance of companionship are captured with this facet [26].
Data analysis and statistical evaluation
Paper-based questionnaires were filled out by patients and subsequently organized using Microsoft Excel 2016 (Microsoft Corporation, Redmond, Washington). The statistic program GraphPad Prism Version 9 (GraphPad Software, Inc. San Diego) was used for statistical testing and generating graphic illustrations. Wilcoxon-matched-pairs test was used for comparison between two groups, and Kruskal–Wallis test was used to compare more than two groups. Boxplots were used for the graphical illustration. In addition to the median, the 25th and 75th percentiles are shown. All points outside the 5th and 95th percentile were presented as outliers as individual values. The significance level was assumed to be p ≤ 0.05.
Results
The study included 31 patients (12 men and 19 women) aged between 71 and 92 years at the survey 6 years after the first CI treatment. The mean age was 79.1 ± 4.8 years. All participants had been treated with a CI unilaterally for the first time due to profound unilateral or bilateral hearing loss 6 years ago. Different implants of the manufacturer Cochlear™ (Cochlear: Cochlear Ltd., Macquarie, Australia) (10 × CI 512, 1 × CI 522, and 8 x CI 532) and MED-EL™ (MED-EL Elektromedizinische Geräte, Gesellschaft m.b.H., Innsbruck, Austria) (15 × Synchrony Mi1200) were used for the initial CI treatment. The average daily CI wearing time 6 years postoperatively was 10.5 ± 4.7 h.
Six patients were also implanted with a CI on the second side during the 6 years after the first CI treatment. In all bilaterally implanted patients, the second ear was implanted no more than 2.5 years after the first. For the second CI, different implants of the company Cochlear™ (2 × CI 512, 1 × CI 522, and 1 × CI 632) and MED-EL™ (2 × Synchrony Mi1200) were used.
Freiburg monosyllabic speech test (FMS)
Six years postoperatively, patients’ monosyllable recognition score with the ear initially treated with a CI at 65 dB SPL averaged 59.5 ± 24.8%. There was no significant difference in FMS between the 6 month (56.5 ± 24.1%; [19]) and 6 year checkup (p = 0.341). From the preoperative measurement under best-aided conditions 14.7 ± 19.9% [19], the monosyllable recognition score increased significantly 6 years postoperatively (p = 0.001) (Fig. 1).
World health organization quality-of-life scale—old (WHOQL-OLD)
WHOQL-OLD “Total score’’
The "Ttotal score" after 6 years was 64.2 ± 10.6 points on average. No significant difference was found in the 6 month follow-up with 66.8 ± 2.2 points [19] (p = 0.12). There was no significant difference comparing the 6 year score with the preoperative score (60.0 ± 15.7 [19]) (p = 0.407) (Fig. 2; Table 1).
WHOQL-OLD “Sensory abilities’’
For the facet “Sensory Abilities”, the mean score 6 years postoperatively was 56.8 ± 15.6. There was no significant difference compared to the control 6 months postoperatively (57.9 ± 12.6 [19]) (p = 0.816). From the preoperative assessment (38.1 ± 22.6 points [19]) to the 6 year control, there was a significant increase (p = 0.002) (Fig. 3; Table 1).
WHOQL-OLD “Autonomy’’
The average score for “Autonomy” 6 years postoperatively was 61.7 ± 12.7 points. A non-significant decrease was observed compared to the 6 month control (65.3 ± 15.3 [19]) (p = 0.074). Overall, there was no significant change throughout the study period (p = 0.866) (Fig. 3; Table 1).
WHOQL-OLD “Past, present, and future activities”
Six years postoperatively, the mean score was 65.1 ± 13.0 points. 6 months postoperatively, the score was 68.4 ± 13.8 [19]. The difference was not significant (p = 0.162). Overall, there was no significant change during the entire study period (p = 0.731) (Fig. 3; Table 1).
WHOQL-OLD ‘‘Social participation’’
For “Social participation”, the score at 6 years postoperatively was 74.2 ± 14.4 points. There was no significant difference to the 6 month control 70.6 ± 13.6 [19] (p = 0.224), but there was a significant difference to the preoperative measurement (61.4 ± 21.0 points [19]) (p = 0.008) (Fig. 3; Table 1).
WHOQL-OLD “Death and dying”
Six years after the initial unilateral CI treatment, the mean score was 57.5 ± 21.8 points. When compared to the 6 month control (65.6 ± 25.1 points [19]), there was no significant decrease (p = 0.282). There were no significant changes over the entire study period (p = 0.36) (Fig. 3; Table 1).
WHOQL-OLD ‘‘Intimacy’’
For the facet “Intimacy”, the average score after 6 years was 69.8 ± 15.5 points. In the 6 months postoperative control (73.0 ± 16.3 points [19]), there was no significant decrease (p = 0.382). Over the entire 6 year period, there was no significant change (p = 0.881) (Fig. 3; Table 1).
Discussion
Over the last decades, the treatment of deaf and severely hearing-impaired patients of all age groups with a CI has become a routine procedure with excellent results in speech understanding for suitable candidates [8, 10, 13, 14, 22, 27, 28]. In recent years, the proportion of CI candidates over the age of 65 has been steadily increasing, with comparable results in speech understanding to younger patients [7, 8]. In recent years, the evaluation of the quality of life has become an integral part of the assessment of treatment success in Germany and is recommended in the German Cochlear Implant Guideline and the German Whitebook on Cochlear Implant Care. These recommendations also form the basis for the new German Cochlear Implant Registry and are a prerequisite for certification as a Cochlear Implant Center in Germany [15,16,17,18].
In our previous study, we also demonstrated a rapid and significant improvement in monosyllabic discrimination within 6 months postoperatively (p = 0.001). The monosyllabic discrimination was stable from the control 6 months postoperatively to the 6 year control (p = 0.341). Our data demonstrate not only a very rapid but also stable improvement in monosyllabic discrimination over the years in elderly patients.
Hearing impairment is a particular risk factor for elderly patients due to the specific psychosocial situation with often increasing physical limitations and resulting in a reduction of social participation [4, 6]. The return to “acoustic social life” due to hearing rehabilitation with CI treatment is, therefore, the basis of improving quality of life and should thus have a central focus in the clinical outcome assessment. Besides the health-related quality of life, such as the widely used Nijmegen Cochlear Implant Questionnaire, general quality-of-life questionnaires are available. As the aim of rehabilitation is, whenever possible, to reach the outcomes of a comparable healthy population, we used the World Health Organization Quality-of-Life Scale -old (WHOQL-OLD) questionnaire to allow the comparison with a healthy age-matched general population [14, 20, 21, 24, 26]. In addition, this questionnaire has been validated specifically for patients over the age of 60. For the total score, as well as for all six facets, there were no significant changes from the control 6 months postoperatively to 6 years postoperatively. However, when comparing the total score from the preoperative measurement to the control 6 years postoperatively, there is no significant difference (p = 0.407) either. To explain these results, the individual facets have to be examined in more detail: The facets “Autonomy” (p = 0.074) and “Past, present and future activities” (p = 0.162) showed a non-significant decrease but clear negative trend in the score from the survey 6 months postoperatively to 6 years postoperatively. In particular, the overperformers decreased. Since the facets “Sensory abilities” (p = 0.816), “Social pParticipation” (p = 0.224), as well as the monosyllabic discrimination (p = 0.342) did not change significantly during this period, other age-related factors not associated with hearing can be assumed as cause.
In monosyllabic discrimination, there was even a slight non-significant increase from the 6 month to the 6 year control. This not only confirms the suspected other factors for the decrease of the total score compared to the 6 year follow-up but also gives evidence for an continuous improvement of the monosyllabic discrimination even after more than 6 months postoperatively in elderly patients. Thus, not only do the poor performers but also the top performers improve further.
To evaluate the results of our study 6 years after hearing rehabilitation with CI, we compared the results to a healthy elderly population, according to Conrad et al. [26] (Table 1). However, the results must be considered in the context of the Conrad et al. cohort being slightly younger, with a mean of 71.3 ± 8.3 years compared to our cohort with 79.1 ± 4.8 years. Regarding the total score, our cohort with a score of 64.2 ± 10.6 does not reach the values of the healthy general population 68.0 ± 14.7 (p = 0.057) even 6 years postoperatively. However, this can also be partially explained by the older age of our cohort and presumably more age-related other infirmities. A closer look at the individual facets reveals significant differences compared to the healthy general population, particularly in the “Sensory abilities” (p = 0.001). The same is true for “Autonomy” (p = 0.001). Thus, although hearing rehabilitation with CI leads to a significant improvement in monosyllabic discrimination, the affected patients assess the performance of their sensory functions significantly worse than the general population. This may be due to a poorer speech comprehension compared to healthy persons despite the CI, but also to persisting everyday problems, especially with hearing in noise. This clearly demonstrates that there is a relevant difference from CI users to the normal hearing. This illustrates the need for further improvement of the CI technology. Possibly also new therapeutic strategies such as optical cochlear implants may help to “close the gap” in the future [29].
Social participation ultimately represents the success of CI treatment that can be directly experienced by each patient. Through hearing rehabilitation with CI, the social deprivation that most elderly hearing impaired patients suffer can usually be successfully reversed [30]. Our data not only indicate stability of “social participation” after hearing rehabilitation for many years, but as the only facet “Social participation” increases—however not significantly—from the control 6 months postoperatively with 70.6 ± 13.6 points to 6 years postoperatively with 74.2 ± 14.4 points (p = 0.1). Interestingly, our study cohort performed better than the general population both at 6 months and 6 years postoperatively (69.0 ± 20.0; p = 0.1).
A critical view on our study reveals potential limitations. Although this is a prospective longitudinal study with a small loss of follow-up of only three patients (8.8%), it is not a randomized controlled study. For ethical reasons, a randomized controlled trial design was not possible. Instead of a control group, a healthy German elderly population, according to Conrad et al. [26], was used. Although this control group is suitable in principle, the data must be considered in the context that the cohort of Conrad et al. [26] is on average almost 8 years younger. As a result, comparisons with the general population according to Conrad et al. are slightly too stringent, as usual age-related changes tending to decrease the quality of life of an older cohort are not considered. Consequently, in addition to the cohort treated with a CI, an age-matched healthy control group would be preferable, that would have to be examined at the same time points. Due to the lack of a sufficient number of healthy age-matched patients, this approach was not feasible.
Ultimately, it is not only the audiological measurable success but rather the return to social life and thus the improvement in quality of life that defines the CI-treatment success experienced by the patient. In summary, our study data indicate a significant increase in “Social participation” in addition to a rapid and stable improvement in monosyllabic discrimination over 6 years. As the only facet, the “Social participation” score continues to increase slightly on average over the years, even better than the average population. As a consequence, in particular elderly CI candidates, should not only be counseled for improvement in speech understanding, but also on the multidimensional positive impact especially on social participation. In addition, a continuous monitoring of the quality of life should be performed routinely during the CI follow-up in order to be able to assess this dimension of the CI-treatment success.
Conclusion
Our study data demonstrate a rapid and stable improvement in quality of life over the 6 years in elderly patients over the age of 65. Moreover, the importance of the systematic assessment of the quality of life, as included in the German Cochlear Implant Guideline and the German Whitebook on Cochlear Implant Care as a central treatment success parameter, is underlined [15,16,17,18]. In particular, “Social participation” as a treatment success directly experienced by the patient reaches the level of the general population within only 6 months postoperatively and even exceeds this level 6 years after CI treatment. Hearing rehabilitation with a CI can be explicitly recommended in case of audiological indication without an age limit. The multidimensional positive effects of CI treatment in elderly patients should also be discussed in detail during preoperative consultation.
References
Carlson ML (2020) Cochlear implantation in adults. N Engl J Med 382(16):1531–1542. https://doi.org/10.1056/NEJMra1904407. (PMID: 32294347)
von Ilberg CA, Baumann U, Kiefer J, Tillein J, Adunka OF (2011) Electric-acoustic stimulation of the auditory system: a review of the first decade. Audiol Neurootol 16(Suppl 2):1–30. https://doi.org/10.1159/000327765
Dazert S, Thomas JP, Loth A, Zahnert T, Stöver T (2020) Cochlear implantation. Dtsch Arztebl Int 117(41):690–700. https://doi.org/10.3238/arztebl.2020.0690
Lin FR, Thorpe R, Gordon-Salant S, Ferrucci L (2011) Hearing loss prevalence and risk factors among older adults in the United States. J Gerontol A Biol Sci Med Sci 66:582–590. https://doi.org/10.1093/gerona/glr002
Roth TN, Hanebuth D, Probst R (2011) Prevalence of age-related hearing loss in Europe: a review. Eur Arch Otorhinolaryngol 268(8):1101–1107. https://doi.org/10.1007/s00405-011-1597-8
Lin FR, Yaffe K, Xia J, Xue QL, Harris TB, Purchase-Helzner E, Satterfield S, Ayonayon HN, Ferrucci L, Simonsick EM (2013) Hearing loss and cognitive decline in older adults. JAMA Intern Med 173:293–299. https://doi.org/10.1001/jamainternmed.2013.1868
Wilkerson BJ, Porps SF, Babu SC (2017) The impact of comorbidities in the aging population on cochlear implant outcomes. Otol Neurotol 38(8):e285–e288. https://doi.org/10.1097/MAO.0000000000001501
Chatelin V, Kim EJ, Driscoll C, Larky J, Polite C, Price L, Lalwani AK (2004) Cochlear implant outcomes in the elderly. Otol Neurotol 25:298–301. https://doi.org/10.1097/00129492-200405000-00017
Illg A, Lenarz T (2022) Cochlear implantation in hearing-impaired elderly: clinical challenges and opportunities to optimize outcome. Front Neurosci 12(16):887719. https://doi.org/10.3389/fnins.2022.887719
Bourn SS, Goldstein MR, Morris SA, Jacob A (2022) Cochlear implant outcomes in the very elderly. Am J Otolaryngol 43(1):103200. https://doi.org/10.1016/j.amjoto.2021.103200
Dillon MT, Buss E, Adunka MC, King ER, Pillsbury HC III, Adunka OF, Buchman CA (2013) Long-term speech perception in elderly cochlear implant users. JAMA Otolaryngol Head Neck Surg 139:279–83. https://doi.org/10.1001/jamaoto.2013.1814
Issing C, Holtz S, Loth AG, Baumann U, Pantel J, Stöver T (2022) Long-term effects on the quality of life following cochlear implant treatment in older patients. Eur Arch Otorhinolaryngol 279(11):5135–5144. https://doi.org/10.1007/s00405-022-07354-2
Wichova H, Mills D, Beatty S, Peng K, Miller M (2022) Cochlear implantation performance outcomes in patients over 80 years old. Laryngoscope Investig Otolaryngol 7(3):847–853. https://doi.org/10.1002/lio2.825
Aimoni C, Ciorba A, Hatzopoulos S, Ramacciotti G, Mazzoli M, Bianchini C, Rosignoli M, Skarżyński H, Skarżyński PH (2016) Cochlear implants in subjects over age 65: quality of life and audiological outcomes. Med Sci Monit 22:3035–3042. https://doi.org/10.12659/msm.896869
https://register.awmf.org/assets/guidelines/017-071l_S2k_Cochlea-Implantat-Versorgung-zentral-auditorische-Implantate_2020-12.pdf last accessed 14 Dec 2023
https://cdn.hno.org/media/2021/ci-weissbuch-20-inkl-anlagen-datenblocke-und-zeitpunkte-datenerhebung-mit-logo-05-05-21.pdf last accessed 14 Dec 2023
Stöver T, Plontke SK, Guntinas-Lichius O et al (2023) Structure and establishment of the German Cochlear Implant Registry (DCIR). HNO 71(Suppl 1):82–92. https://doi.org/10.1007/s00106-023-01310-0
Stöver T, Plontke SK, Guntinas-Lichius O et al (2023) Conception and implementation of a certification system for quality control of cochlear implant treatment in Germany. HNO 71(Suppl 1):73–81. https://doi.org/10.1007/s00106-023-01306-w
Issing C, Baumann U, Pantel J, Stöver T (2020) Cochlear implant therapy improves the quality of life in older patients—a prospective evaluation study. Otol Neurotol 41(9):1214–1221. https://doi.org/10.1097/MAO.0000000000002741
Wick CC, Kallogjeri D, McJunkin JL, Durakovic N, Holden LK, Herzog JA, Firszt JB, Buchman CA, CI532 Study Group (2020) Hearing and quality-of-life outcomes after cochlear implantation in adult hearing aid users 65 years or older: a secondary analysis of a nonrandomized clinical trial. JAMA Otolaryngol Head Neck Surg 146(10):925–932. https://doi.org/10.1001/jamaoto.2020.1585
Sonnet MH, Montaut-Verient B, Niemier JY, Hoen M, Ribeyre L, Parietti-Winkler C (2017) Cognitive abilities and quality of life after cochlear implantation in the elderly. Otolo Neurotol 38:e296–e301. https://doi.org/10.1097/mao.0000000000001503
Völter C, Götze L, Haubitz I, Dazert S, Thomas JP (2020) Benefits of cochlear implantation in middle-aged and older adults. Clin Interv Aging 15:1555–1568. https://doi.org/10.2147/CIA.S255363
Vermeire K, Brokx JP, Wuyts FL, Cochet E, Hofkens A, Van de Heyning PH (2005) Quality-of-life benefit from cochlear implantation in the elderly. Otol Neurotol 26(2):188–195. https://doi.org/10.1097/00129492-200503000-00010
Hinderink JB, Krabbe PF, Van Den Broek P (2000) Development and application of a health-related quality-of-life instrument for adults with cochlear implants: the Nijmegen cochlear implant questionnaire. Otolaryngol Head Neck Surg 123:756–765. https://doi.org/10.1067/mhn.2000.108203
Mosnier I, Bebear J-P, Marx M, Fraysse B, Truy E, Lina-Granade G, Mondain M, Sterkers-Artières F, Bordure P, Robier A, Godey B, Meyer B, Frachet B, Poncet-Wallet C, Bouccara D, Sterkers O (2015) Improvement of cognitive function after cochlear implantation in elderly patients. JAMA Otolaryngol 141:442–450. https://doi.org/10.1001/jamaoto.2015.129
Conrad I, Matschinger H, Kilian R Riedel-Heller S (2000) WHOQOL-OLD und WHOQOL-BREF. Handbuch für die deutschsprachigen Versionen der WHO-Instrumente zur Erfassung der Lebensqualität im Alter. [in German] Hogrefe, Göttingen
Buchman CA, Fucci MJ, Luxford WM (1999) Cochlear implants in the geriatric population: benefits outweigh risks. Ear Nose Throat J 78:489–494
Hilly O, Hwang E, Smith L, Shipp D, Nedzelski JM, Chen JM, Lin VW (2016) Cochlear implantation in elderly patients: stability of outcome over time. J Laryngol Otol 130:706–711. https://doi.org/10.1017/s0022215116008197
Dieter A, Keppeler D, Moser T (2020) Towards the optical cochlear implant: optogenetic approaches for hearing restoration. EMBO Mol Med 12(4):e11618. https://doi.org/10.15252/emmm.201911618
Arlinger S (2003) Negative consequences of uncorrected hearing loss—a review. Int J Audiol 42(Suppl 2):17–20
Funding
Open Access funding enabled and organized by Projekt DEAL. The authors received no specific funding for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
The study was conducted in accordance with the Declaration of Helsinki 1964, and with approval of the local ethical review committee (105/15). All patients gave their written informed consent for inclusion before they participated in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Issing, C., Loth, A.G., Sakmen, K.D. et al. Cochlear implant therapy improves the quality of life and social participation in the elderly: a prospective long-term evaluation. Eur Arch Otorhinolaryngol 281, 3453–3460 (2024). https://doi.org/10.1007/s00405-023-08443-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08443-6